SEKRX
Price
$22.50
Change
-$0.10 (-0.44%)
Updated
Sep 25 closing price
Net Assets
65.04M
VEMIX
Price
$33.91
Change
-$0.15 (-0.44%)
Updated
Sep 25 closing price
Net Assets
130.49B
Interact to see
Advertisement

SEKRX vs VEMIX

Header iconSEKRX vs VEMIX Comparison
Open Charts SEKRX vs VEMIXBanner chart's image
DWS Emerging Markets Equity R6
Price$22.50
Change-$0.10 (-0.44%)
VolumeN/A
Net Assets65.04M
Vanguard Emerging Mkts Stock Idx Instl
Price$33.91
Change-$0.15 (-0.44%)
VolumeN/A
Net Assets130.49B
SEKRX vs VEMIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SEKRX vs. VEMIX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SEKRX is a Buy and VEMIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 130B vs. SEKRX (65M). VEMIX pays higher dividends than SEKRX: VEMIX (2.68) vs SEKRX (0.21). SEKRX was incepted earlier than VEMIX: SEKRX (7 years) vs VEMIX (25 years). SEKRX (1.27) is less costly to investors than VEMIX (0.09). SEKRX is a more actively managed with annual turnover of: 61.00 vs. VEMIX (8.00). SEKRX has a lower initial minimum investment than VEMIX: SEKRX (0) vs VEMIX (5000000). SEKRX (18.60) and VEMIX (17.95) have marching annual gain over last year. VEMIX return over 5 years is better than : 40.50 vs. SEKRX (19.06).
SEKRXVEMIXSEKRX / VEMIX
Total Expense Ratio0.920.091,022%
Annual Report Gross Expense Ratio1.270.091,411%
Fund Existence7 years25 years-
Gain YTD23.22822.513103%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets65M130B0%
Annual Yield % from dividends0.212.688%
Returns for 1 year18.6017.95104%
Returns for 3 years47.7755.0687%
Returns for 5 years19.0640.5047%
Returns for 10 yearsN/A97.31-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FITBP24.80-0.03
-0.12%
Fifth Third Bancorp
SLVM42.62-0.14
-0.33%
Sylvamo Corp
HALO73.97-1.67
-2.21%
Halozyme Therapeutics
ETHZ2.33-0.11
-4.51%
ETHZilla Corporation
SST7.34-0.59
-7.44%
System1